Nemaura Medical Announces Appointment of Mr Nikolai Rozanov as Strategic Adviser in Artificial Intelligence, to Assist in Development of its AI Health Coach, and Strengthen Outcomes in its CGM Based Metabolic and Type 2 Diabetes Programs.
September 26, 2023 09:50 ET
|
Nemaura Medical, Inc
LOUGHBOROUGH, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc.(NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercialising non-invasive...
Nemaura Medical to Present at the Sidoti & Co. Micro Cap Virtual Conference
January 11, 2023 08:00 ET
|
Nemaura Medical, Inc
Loughborough, England, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic...
Nemaura Medical to Present at the Planet MIcroCap Showcase: Virtual 2022
December 01, 2022 08:15 ET
|
Nemaura Medical, Inc
Loughborough, England, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic...
Nemaura Medical Appoints Dr. Arash Ghadar as Chief Operating Officer
January 10, 2022 08:00 ET
|
Nemaura Medical, Inc
Loughborough, England, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Announces Progress on Listing of sugarBEAT® For Reimbursement in Germany
May 06, 2021 08:00 ET
|
Nemaura Medical, Inc
Loughborough, England, May 06, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Announces Order for 200,000 sugarBEAT® Sensors
May 05, 2021 08:00 ET
|
Nemaura Medical, Inc
Based on the success of the soft launch in the U.K., the Company is advancing discussions for joint launches in Germany, Saudi Arabia and UAE Loughborough, England, May 05, 2021 (GLOBE...
Nemaura Medical Issues Letter to Shareholders Following April 28 Shareholder Update Call
April 29, 2021 08:04 ET
|
Nemaura Medical, Inc
Loughborough, England, April 29, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...